AI Verdict
KURA has stronger fundamentals based on our AI analysis.
KW vs KURA Fundamental Comparison
| Metric | KW | KURA |
|---|---|---|
| Revenue | $501.0M | $67.5M |
| Net Income | $-38.8M | $-278.7M |
| Net Margin | -7.7% | -412.9% |
| ROE | -2.5% | -160.0% |
| ROA | -0.6% | -37.7% |
| Current Ratio | N/A | 6.06x |
| Debt/Equity | 2.87x | 0.06x |
| EPS | $-0.28 | $-3.18 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KW vs KURA: Frequently Asked Questions
Is KW or KURA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KURA has stronger fundamentals. KW is rated STRONG SELL (88% confidence) while KURA is rated HOLD (72% confidence). This is not investment advice.
How does KW compare to KURA fundamentally?
Kennedy-Wilson Holdings, Inc. has ROE of -2.5% vs Kura Oncology, Inc.'s -160.0%. Net margins are -7.7% vs -412.9% respectively.
Which stock pays higher dividends, KW or KURA?
KW has a dividend yield of N/A or no dividend while KURA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KW or KURA for long term?
For long-term investing, consider that KW has STRONG SELL rating with 88% confidence, while KURA has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KW vs KURA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KW vs KURA, the AI consensus favors KURA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.